Duration of antiviral immunity after smallpox vaccination (Q43485360)

23 November 2017

title

Duration of antiviral immunity after smallpox vaccination (English)

1 reference

23 November 2017

1 reference

0 references

8

Mark K Slifka

1 reference

23 November 2017

1

Erika Hammarlund

1 reference

23 November 2017

Matthew W Lewis

2

1 reference

23 November 2017

Scott G Hansen

3

1 reference

23 November 2017

Lisa I Strelow

4

1 reference

23 November 2017

Jay A Nelson

5

1 reference

23 November 2017

Gary J Sexton

6

1 reference

23 November 2017

Jon M Hanifin

7

1 reference

23 November 2017

language of work or name

English

0 references

publication date

17 August 2003

1 reference

23 November 2017

1 reference

23 November 2017

volume

9

1 reference

23 November 2017

issue

9

1 reference

23 November 2017

page(s)

1131-1137

1 reference

The looming threat of bioterrorism

23 November 2017

cites work

1 reference

7 January 2021

Modeling potential responses to smallpox as a bioterrorist weapon

1 reference

7 January 2021

Transmission potential of smallpox in contemporary populations

1 reference

7 January 2021

Emergency response to a smallpox attack: the case for mass vaccination.

1 reference

7 January 2021

Shining light on "Dark Winter".

1 reference

7 January 2021

Smallpox: anything to declare?

1 reference

7 January 2021

A prospective study of serum antibody and protection against smallpox

1 reference

7 January 2021

The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox

1 reference

7 January 2021

Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

1 reference

7 January 2021

The persistence of neutralizing antibodies after revaccination against smallpox

1 reference

7 January 2021

Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses

1 reference

7 January 2021

Ex vivo detection and enumeration of human antigen-specific CD8+ T lymphocytes using antigen delivery by a recombinant vaccinia expression vector and intracellular cytokine staining

1 reference

7 January 2021

The antibody response in man following infection with viruses of the pox group. II. Antibody response following vaccination

1 reference

7 January 2021

Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination

1 reference

7 January 2021

Response to smallpox vaccine in persons immunized in the distant past

1 reference

7 January 2021

1 reference

7 January 2021

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

1 reference

7 January 2021

Smallpox in Europe, 1950-1971

1 reference

7 January 2021

Studies in smallpox and vaccination. 1913.

1 reference

7 January 2021

A study of inapparent infection in smallpox

1 reference

7 January 2021

Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies

1 reference

7 January 2021

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

1 reference

7 January 2021

Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions

1 reference

7 January 2021

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

1 reference

7 January 2021

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

1 reference

7 January 2021

Characterization of CD4(+) CTLs ex vivo

1 reference

7 January 2021

Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.

1 reference

7 January 2021

Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones

1 reference

7 January 2021

Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans

1 reference

7 January 2021

Diagnosis and management of smallpox

1 reference

7 January 2021

Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus

1 reference

7 January 2021

Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes

1 reference

7 January 2021

Anti-vaccinial gamma-globulin in smallpox prophylaxis

1 reference

7 January 2021

Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity

1 reference

7 January 2021

Responses to smallpox vaccine

1 reference

7 January 2021

Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM917

1 reference

Dimensions Publication ID

23 November 2017

1049303618

0 references

1 reference